Continue to Site

Morningside Pharmaceuticals donates 60,000 packs of medicine to Ukraine

By Brian Buntz | April 12, 2022

The generic and branded pharmaceutical manufacturer Morningside Pharmaceuticals has donated roughly 60,000 medicine packs to support Ukrainian relief efforts.

The donation will encompass 1.29 million doses of essential medicines.

The Loughborough, UK–based company announced the donation after the company’s founder Dr. Nik Kotecha spoke with the Ukrainian Ambassador to the United Kingdom, Vadym Prystaiko.

“The heartbreaking situation in Ukraine has touched us all, and as like so many people in the United Kingdom, we’ve been keen to do everything we can to help the victims of this terrible conflict,” Kotecha said.

Morningside Pharmaceuticals enlisted a logistics partner to transport the medicine via a secure and temperature-controlled environment to war-torn Ukrainian regions.

Morningside had previously supported the Ukrainian relief effort by donating goods such as diapers, feminine hygiene packs, sleeping bags and items for children.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.